- Home
- INCY vs LOGI Comparison
INCY vs LOGI Comparison
Compare INCY & LOGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCY
- LOGI
- Stock Information
- Founded
- INCY 1991
- LOGI 1981
- Country
- INCY United States
- LOGI Switzerland
- Employees
- INCY N/A
- LOGI N/A
- Industry
- INCY Biotechnology: Commercial Physical & Biological Resarch
- LOGI Computer peripheral equipment
- Sector
- INCY Health Care
- LOGI Technology
- Exchange
- INCY Nasdaq
- LOGI Nasdaq
- Market Cap
- INCY 13.4B
- LOGI 11.0B
- IPO Year
- INCY 1993
- LOGI 1997
- Fundamental
- Price
- INCY $65.06
- LOGI $82.76
- Analyst Decision
- INCY Hold
- LOGI Buy
- Analyst Count
- INCY 19
- LOGI 8
- Target Price
- INCY $72.67
- LOGI $85.71
- AVG Volume (30 Days)
- INCY 1.8M
- LOGI 762.9K
- Earning Date
- INCY 04-29-2025
- LOGI 07-21-2025
- Dividend Yield
- INCY N/A
- LOGI 1.65%
- EPS Growth
- INCY N/A
- LOGI 6.72
- EPS
- INCY 0.10
- LOGI 4.13
- Revenue
- INCY $4,413,226,000.00
- LOGI $4,554,900,000.00
- Revenue This Year
- INCY $13.29
- LOGI $4.66
- Revenue Next Year
- INCY $10.43
- LOGI $5.43
- P/E Ratio
- INCY $592.09
- LOGI $19.48
- Revenue Growth
- INCY 17.13
- LOGI 5.97
- 52 Week Low
- INCY $53.56
- LOGI $64.73
- 52 Week High
- INCY $83.95
- LOGI $105.65
- Technical
- Relative Strength Index (RSI)
- INCY 60.01
- LOGI 49.23
- Support Level
- INCY $63.51
- LOGI $83.72
- Resistance Level
- INCY $66.26
- LOGI $85.32
- Average True Range (ATR)
- INCY 1.60
- LOGI 1.23
- MACD
- INCY 0.32
- LOGI -0.24
- Stochastic Oscillator
- INCY 83.12
- LOGI 9.08
About INCY Incyte Corp.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
About LOGI Logitech International S.A.
Logitech was founded in 1981 and is headquartered in Lausanne, Switzerland. The company specializes in designing and manufacturing computer peripherals such as mice, keyboards, webcams, conference room cameras, headsets, and music-related products like wireless speakers.